capabilities to revolutionize clinical trial protocol development and management. This collaboration integrates Egnyte's Content Intelligence Engine and AI Copilot technology with Espero's AI ...
Q4 2024 Management View CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ...
With this new phase 2 protocol, Allarity will capitalize and expand on the ongoing phase 2 clinical trial data to optimize the dose of ... approval to further enable stenoparib’s clinical development.
Conduit Pharmaceuticals advances its pipeline with key progress in preclinical lupus studies for AZD5658, Phase IIa trial design for AZD1656, formulation optimization, and IP expansion, positioning ...